Clinical Trials
7 trialsNCT00728585 2018-08-07
Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant
Children's Oncology Group
Phase 2 Withdrawn
NCT00626639 2017-06-21
A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy
Swedish Orphan Biovitrum
Phase 1/2 Completed
NCT00131638 2016-12-16
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer
Amgen
Phase 3 Completed
NCT00434161 2015-03-30
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma
Swedish Orphan Biovitrum
Phase 3 Completed
NCT00109031 2014-09-15
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
Swedish Orphan Biovitrum
Phase 3 Completed
NCT00393822 2014-07-15
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer
Amgen
Phase 2/3 Completed
NCT00540332 2009-03-02
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy
Swedish Orphan Biovitrum
Phase 1/2 Withdrawn